Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 865 of 1,261
  1. US 8476236

    Treatment of skin conditions by Dickkopf1 (DKK1)

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted
  2. CA 2858984

    UTILISATION D'UN C1-INHIBITEUR DESTINE AU TRAITEMENT D'UN OEDEME SECONDAIRE DU SYSTEME NERVEUX CENTRAL

    CSL BEHRING GMBH [DE] · Granted Jun 27, 2013 · Expires Jun 22, 2033

    granted
  3. US 8470789

    Method for inducing and accelerating cells

    DCPRIME B.V. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  4. US 8470326

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  5. US 8470976

    Methods and compositions for targeting macromolecules into the nucleus

    The Board of Regents of the University of Texas System · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  6. US 8470988

    Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety

    Alnylam Pharmaceuticals, Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  7. US 8470888

    Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  8. US 8470872

    Compounds with activity at estrogen receptors

    ACADIA Pharmaceuticals Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  9. US 8471029

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  10. US 8470799

    Compositions and methods for inhibiting expression of the HAMP gene

    Alnylam Pharmaceuticals, Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  11. US 8470301

    Particulate materials

    Nektar Therapeutics · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  12. US 8470296

    Intracorporeal medicaments for high energy phototherapeutic treatment of disease

    Provectus Pharmatech, Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  13. US 8469899

    Management of gastro-intestinal disorders

    EXALENZ BIOSCIENCE LTD. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  14. US 8470312

    Abrogating proinflammatory cytokine production during oncolytic reovirus therapy

    ONCOLYTICS BIOTECH INC. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  15. US 8470324

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  16. US 8470342

    Methods of altering an immune response induced by CpG oligodeoxynucleotides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  17. US 8470520

    Decellularization and recellularization of organs and tissues

    Regents of the University of Minnesota · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  18. US 8470344

    Aqueous dispersions and solutions of difficult to dissolve materials and methods of their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  19. US 8470364

    Once daily formulations of tetracyclines

    Supernus Pharmaceuticals, Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  20. US 8470528

    Methods and compositions related to adenoassociated virus-phage particles

    The Board of Regents of the University of Texas System · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  21. US 8470545

    Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)

    The Regents of the University of California · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  22. US 8470816

    Nitrogen-containing heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  23. US 8470859

    Iminopyridine derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  24. US 8471040

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.